Stay updated with breaking news from Symphony Acquisition Sub. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has successfully completed its acquisition of Decibel Therapeutics, Inc., strengthening the company’s gene therapy and auditory programs. The acquisition of Decibel builds on prior collaboration between the companies and includes three ongoing ...
TARRYTOWN, N.Y., Sept. 25, 2023 -- Regeneron Pharmaceuticals, Inc. today announced that it has successfully completed its acquisition of Decibel Therapeutics, Inc., strengthening the company’s...
TENDER AND SUPPORT AGREEMENT This TENDER AND SUPPORT AGREEMENT , dated as of August 8, 2023, is entered into by and among Regeneron Pharmaceuticals, Inc., a New...
Proposed acquisition builds on existing collaboration between Decibel and Regeneron, will accelerate and further resource key gene therapy programs for hearing loss Decibel’s lead...
Tarrytown-based Regeneron Pharmaceuticals through its wholly owned subsidiary Symphony Acquisition Sub, Inc., is acquiring a Boston company it has been working with for several years. The company is Decibel Therapeutics, with which Regeneron has been collaborating on using gene therapy to combat hearing loss. Decibel describes itself as being exclusively focused on discovering and developing […]